Comparisons

Wegovy vs Saxenda: Comparing Semaglutide and Liraglutide for Weight Loss

Wegovy vs Saxenda: Comparing Semaglutide and Liraglutide for Weight Loss

If you're considering a GLP-1 medication for weight loss, you've likely come across both Wegovy and Saxenda. These two FDA-approved medications have helped thousands of people achieve significant weight loss, but they're not identical.

Wegovy contains semaglutide, while Saxenda contains liraglutide. Both belong to the GLP-1 receptor agonist family, but they differ in how often you take them, how effective they are, and what you might experience along the way.

Let's break down the key differences between Wegovy vs Saxenda so you can understand which option might work better for your weight loss journey.

What Are Wegovy and Saxenda?

Both Wegovy and Saxenda are injectable prescription medications that work by mimicking a natural hormone called GLP-1 (glucagon-like peptide-1). This hormone helps regulate appetite, blood sugar, and digestion.

Wegovy (semaglutide) was approved by the FDA in 2021 specifically for chronic weight management. It's a once-weekly injection that has become one of the most talked-about weight loss medications available.

Saxenda (liraglutide) received FDA approval for weight management in 2014. It requires a daily injection, which means a different commitment level compared to Wegovy.

Both medications are intended for adults with obesity (BMI of 30 or greater) or those who are overweight (BMI of 27 or greater) with at least one weight-related health condition like high blood pressure or type 2 diabetes.

How Effective Is Semaglutide vs Liraglutide for Weight Loss?

When it comes to effectiveness, clinical trials show some clear differences between these two medications.

In the STEP trials for Wegovy, participants lost an average of 15-17% of their body weight over 68 weeks. Some people lost even more, with many achieving 20% or greater weight loss when combined with lifestyle changes.

Saxenda's clinical trials showed an average weight loss of 5-10% of body weight over 56 weeks. While this is still clinically significant and can lead to meaningful health improvements, it's notably less than what's typically seen with semaglutide.

The difference in effectiveness comes down to how these medications work at a molecular level. Semaglutide has a longer half-life and binds more strongly to GLP-1 receptors, which translates to more sustained appetite suppression and greater weight loss results.

Dosing and Administration: Weekly vs Daily

One of the most practical differences between Wegovy and Saxenda is how often you need to take them.

Wegovy is administered once weekly via a pre-filled injection pen. You start at a low dose (0.25 mg) and gradually increase every four weeks until reaching the maintenance dose of 2.4 mg weekly. This slow titration helps minimize side effects.

Saxenda requires daily injections, starting at 0.6 mg and increasing by 0.6 mg each week until reaching the maintenance dose of 3.0 mg daily. That means you're injecting yourself seven times as often compared to Wegovy.

For many people, the convenience of a once-weekly injection makes Wegovy more appealing. However, others prefer the flexibility of adjusting their dose more frequently with a daily medication.

Side Effects: What to Expect

Because both medications work similarly, they share many of the same side effects. The most common ones include nausea, diarrhea, constipation, vomiting, and abdominal pain.

These gastrointestinal side effects are usually most noticeable when starting the medication or increasing your dose. They typically improve over time as your body adjusts.

In clinical trials, Wegovy and Saxenda showed similar rates of side effects, though some studies suggest nausea may be slightly more common with Saxenda due to the daily dosing pattern.

Both medications carry similar warnings about potential thyroid tumors (based on animal studies), pancreatitis, and gallbladder problems. Your healthcare provider will review your medical history to ensure either medication is safe for you.

Cost Comparison: Wegovy vs Saxenda

Cost is often a major factor when choosing between these medications. Without insurance, both Wegovy and Saxenda are expensive.

The list price for Wegovy is approximately $1,300-$1,400 per month. Saxenda typically costs around $1,300-$1,500 per month. Neither medication is consistently covered by insurance for weight loss, though coverage varies by plan.

This is where compounded versions of these medications become relevant. Compounded semaglutide offers the same active ingredient as Wegovy at a significantly lower cost, making this highly effective treatment accessible to more people.

For more information about medication options and costs, you can explore additional resources at ozarihealth.com/blog.

Which One Is Right for You?

Choosing between Wegovy and Saxenda depends on several factors, including your weight loss goals, lifestyle, budget, and personal preferences.

Wegovy may be the better choice if you want maximum weight loss results, prefer once-weekly dosing, and are looking for the most effective GLP-1 option currently available.

Saxenda might work for you if you prefer daily dosing that allows for more frequent adjustments, or if you've already had success with liraglutide for diabetes management.

Ultimately, this decision should be made with your healthcare provider, who can evaluate your medical history, current health status, and treatment goals to recommend the best option for your situation.

Key Takeaways

Frequently Asked Questions

Can I switch from Saxenda to Wegovy?

Yes, you can switch from Saxenda to Wegovy under medical supervision. Your healthcare provider will determine the appropriate starting dose of Wegovy based on your current Saxenda dose and how well you've tolerated it. There's typically no required waiting period between stopping one medication and starting the other, though your doctor may recommend a specific transition plan.

How long does it take to see results with Wegovy vs Saxenda?

Most people begin seeing weight loss within the first 4-8 weeks of treatment with either medication. However, maximum results typically occur after several months of consistent use at the full maintenance dose. Wegovy users often see more significant weight loss by the 3-6 month mark, while Saxenda may take the full 56 weeks to achieve peak results.

Are Wegovy and Saxenda safe for long-term use?

Both medications have been studied for long-term use and are considered safe for ongoing weight management when prescribed appropriately. Clinical trials for Wegovy lasted up to 68 weeks, and Saxenda trials extended to 56 weeks, with many patients continuing treatment beyond the study periods. However, long-term use should always be monitored by your healthcare provider with regular check-ins to assess effectiveness and safety.

At Ozari Health, we offer compounded Semaglutide and Tirzepatide as low as $99/month, prescribed by licensed providers and shipped to your door. Learn more at ozarihealth.com.

Reviewed by the Ozari Clinical Content Team (OCCT) — health writers and wellness professionals specializing in GLP-1 therapy and metabolic health. This content is for informational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before starting any medication.